- "Two recent federal appeals court rulings upheld that some of Boston Scientific's neuromodulation patents were invalid, as part of ongoing litigation between the medtech giant and Nevro over their respective spinal cord stimulation devices.
- A panel of judges in the U.S. Court of Appeals for the Federal Circuit ruled on Friday that Boston Scientific's patent for a spinal cord stimulation implant was invalid, upholding a previous decision by the Patent Trial and Appeal Board. Earlier this month, a separate group of judges made a similar ruling related to a different Boston Scientific patent, for telemetry systems and methods of communicating with an implantable stimulator."
Director Jon E. Wright was quoted in the article "US Appeals Court Rules in Favor of Nevro in Patent Dispute With Boston Scientific," published by MedTech Dive. Wright led the team representing Nevro Corp., which also included Counsel Richard A. Crudo and Associate Naveed S. Hasan.